Canada Spends Logo

Explore our Budget 2026 analysis

Grant: China-Canada Joint Health Research Initiative

McGill University

$150,000.00

Role of the epigenetic regulator Bmi1 in mediating the anti-aging effect of parathyroid hormone-related peptide

FY 2008-09

Summary
As we manage major human diseases more efficiently than before, population aging becomes an increasingly serious social and economic problem that puts a heavy burden on the health care system. Major advances in aging research are expected to result in novel means for delaying aging, preventing diseases and improving health. An important aspect in this emerging research field is to study genes with key roles in regulation of aging and longevity. One such gene encodes a protein called Bmi1, which is also an important regulator for the growth and proliferation of different stem cells. Bmi1 is mainly localized to the nucleus, where it controls the packaging of the genetic material DNA by affecting modification of proteins involved in the packaging process. An important question is how nuclear regulators like Bmi1 respond to the extracellular environment or signaling cues from the outside of the cells. In this regard, the parathyroid hormone-related peptide (or PTHrP) is a unique hormone as it not only binds to receptors on the cell membrane but also directly translocates to the nucleus. We have recently found that PTHrP interacts with Bmi1. Consistent with this, mouse genetic studies have established that PTHrP acts upstream from Bmi1. In addition, we found that Bmi1 associates with histone deacetylase 3, another regulator in the nucleus. Our working hypothesis is that as one mechanism of action, PTHrP translocates to the nucleus and interacts with Bmi1 and the deacetylase to directly regulate the packaging of the genetic material. In the current joint application, we propose to take molecular, cellular and genetic approaches for dissecting the underlying mechanisms and gain new insights into how the PTHrP-Bmi1 signaling axis plays a role in cellular and organismal aging.
Program
China-Canada Joint Health Research Initiative
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
182773
Name
Yang Xiang-Jiao
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Partnername
National Natural Science Foundation of China (Haidian, Beijing)
Instname2
Aging
Theme2
Biomedical
Prcname2
China-Canada Joint Health Research Initiative - Grants Program
Projecttitle
Role of the epigenetic regulator Bmi1 in mediating the anti-aging effect of parathyroid hormone-related peptide
Programtype2
Operating Grants
Orgnameinp2
McGill University
Cihramount2
$150,000
Cihrequipment2
$0
Programname2
China-Canada Joint Health Research Initiative
Keyworddelim
Aging; Chromatin; Endocrine Hormone; Epigenetics; Gene Regulation; Stem Cells
Abstract
As we manage major human diseases more efficiently than before, population aging becomes an increasingly serious social and economic problem that puts a heavy burden on the health care system. Major advances in aging research are expected to result in novel means for delaying aging, preventing diseases and improving health. An important aspect in this emerging research field is to study genes with key roles in regulation of aging and longevity. One such gene encodes a protein called Bmi1, which is also an important regulator for the growth and proliferation of different stem cells. Bmi1 is mainly localized to the nucleus, where it controls the packaging of the genetic material DNA by affecting modification of proteins involved in the packaging process. An important question is how nuclear regulators like Bmi1 respond to the extracellular environment or signaling cues from the outside of the cells. In this regard, the parathyroid hormone-related peptide (or PTHrP) is a unique hormone as it not only binds to receptors on the cell membrane but also directly translocates to the nucleus. We have recently found that PTHrP interacts with Bmi1. Consistent with this, mouse genetic studies have established that PTHrP acts upstream from Bmi1. In addition, we found that Bmi1 associates with histone deacetylase 3, another regulator in the nucleus. Our working hypothesis is that as one mechanism of action, PTHrP translocates to the nucleus and interacts with Bmi1 and the deacetylase to directly regulate the packaging of the genetic material. In the current joint application, we propose to take molecular, cellular and genetic approaches for dissecting the underlying mechanisms and gain new insights into how the PTHrP-Bmi1 signaling axis plays a role in cellular and organismal aging.
Competitiondate
200903
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Yang, Xiang-Jiao; Miao, Dengshun
Approvedterm
3 ans 0 mois
Cihrcontribution2
Institute of Aging~ $150,000~ $0~
McGill University - $150,000 Grant (2008-09) | Canada Spends